Fig. 2From: Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation studyKaplan–Meier curves for overall survival (OS) (A) and stratified by clinical characteristics, including (B) brain metastasis, (C) bone metastasis, (D) liver metastasis, (E) gene status. Note: EGFR (epidermal growth factor receptor), including classical EGFR mutation and unclassical EGFR mutationBack to article page